7773
富禾生醫
-1.14%
(-0.01)
富禾生醫 (7773.TW) 2025 financial report shows revenue of 43.6M TWD, with a YoY growth rate of 112.63%. This outstanding figure clearly proves the company’s exceptionally strong operational momentum and significant expansion in market demand. To accurately capture 富禾生醫 (7773.TW)’s future growth potential, investors should closely follow subsequent financial reports and key strategic movements, and deeply integrate diversified data and tools such as Growin AI Value Analysis for a comprehensive and forward-looking strategic assessment.